(Report ID: 39002) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,583 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 8,241 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 39002 | Dec, 23, 2005 | Not specified | Female |
List of drugs the patient takes:
Results from eHealthMe: 8,241 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Breast Cancer | 4,096 (49.70%) |
Death: 1 (0.07% of total reports)
Cancer: 1,256 (92.90% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 775 (57.32%) |
2 | Breast Cancer Metastatic | 335 (24.78%) |
3 | Deep Vein Thrombosis | 53 (3.92%) |
4 | Breast Cancer Female | 43 (3.18%) |
5 | Pulmonary Embolism | 40 (2.96%) |
6 | Cerebrovascular Accident | 39 (2.88%) |
7 | Myocardial Infarction | 29 (2.14%) |
8 | Ovarian Cancer Metastatic | 28 (2.07%) |
9 | Breast Cancer In Situ | 22 (1.63%) |
10 | Thrombosis | 22 (1.63%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Provera | 935 |
2 | Cycrin | 197 |
3 | Estrace | 82 |
4 | Fosamax | 55 |
5 | Conjugated Estrogens | 39 |
6 | Estraderm | 36 |
7 | Estradiol | 23 |
8 | Estratab | 21 |
9 | Prometrium | 21 |
10 | Femhrt | 20 |
Death: 4 (0.05% of total reports)
Cancer: 7,858 (95.35% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 4,096 (49.70%) |
2 | Breast Cancer Female | 2,122 (25.75%) |
3 | Breast Cancer Metastatic | 882 (10.70%) |
4 | Oestrogen Receptor Assay Positive | 454 (5.51%) |
5 | Progesterone Receptor Assay Positive | 395 (4.79%) |
6 | Breast Cancer In Situ | 257 (3.12%) |
7 | Deep Vein Thrombosis | 205 (2.49%) |
8 | Cerebrovascular Accident | 201 (2.44%) |
9 | Ovarian Cancer | 196 (2.38%) |
10 | Pulmonary Embolism | 175 (2.12%) |
| Name | Count |
1 | Provera | 6,459 |
2 | Cycrin | 1,176 |
3 | Estrace | 692 |
4 | Estraderm | 341 |
5 | Estradiol | 299 |
6 | Activella | 243 |
7 | Femhrt | 211 |
8 | Climara | 199 |
9 | Estratab | 199 |
10 | Prometrium | 150 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
